Wednesday, May 05, 2021 6:05:05 PM
Many companies dont discuss up-coming FDA meetings or applications from what I have read.
Of course I hope for the surprise of an Earlier date and results. Under promise and over deliver would be a nice change.
Lung X-rays?
AP needs to drop the current IPF/CC Trial/failure and somehow combine all those efforts toward Endpoints of a Phase 3 CT for Ifenprodil that may be achievable. Maybe CM can then find a Partner.
...GLTA...
Some 'Exciting Hype' of an Ifenprodil/DMT micro-dose combo for their Stroke "Research", even.?.
Fkn calculate a dosage and write a procedure/Thesis, then try it on the Fkn mice. Then patent it. JMHFO...
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM